About Encision (OTCMKTS:ECIA)
Encision Inc. is a medical device company. The Company designs, develops, manufactures and markets surgical instruments that provide safety to patients undergoing minimally-invasive surgery. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death. Its shielded and monitored instruments enable surgeons to perform electrosurgical procedures. It produces and markets a line of AEM Instruments, which are shielded and monitored to prevent stray electrosurgical burns from insulation failure and capacitive coupling. Its product line includes a range of endo-mechanical instruments (scissors, graspers and dissectors), fixed-tip electrodes and suction-irrigation electrodes. Its EndoShield integrates its AEM technology into a disposable smart cord and eliminates the need for a separate AEM monitor.
Industry, Sector and Symbol
Industry Medical Instruments & Supplies
Trailing P/E Ratio13.3377792597533
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$8.87 million
Price / Sales0.48
Price / CashN/A
Book Value$0.21 per share
Price / Book1.90
Return on Equity11.72%
Return on Assets7.61%
Encision (OTCMKTS:ECIA) Frequently Asked Questions
What is Encision's stock symbol?
Encision trades on the OTCMKTS under the ticker symbol "ECIA."
How were Encision's earnings last quarter?
Encision Inc (OTCMKTS:ECIA) announced its quarterly earnings data on Monday, February, 5th. The medical device company reported $0.01 EPS for the quarter. The medical device company had revenue of $2.19 million for the quarter. Encision had a return on equity of 11.72% and a net margin of 2.67%. View Encision's Earnings History.
When will Encision make its next earnings announcement?
Who are some of Encision's key competitors?
Some companies that are related to Encision include Delcath Systems (DCTHD), Zosano Pharma (ZSAN), Argos Therapeutics (ARGS), Immune Pharmaceuticals (IMNP), Mateon Therapeutics (MATN), Sunshine Heart (CHFS), Secure Point Technologies (IMSC), Strata Skin Sciences (SSKN), Dextera Surgical (DXTR), Lombard Medical (EVARF), TearLab (TEAR), Affymax (AFFY), BG Medicine (BGMD), Reneuron Group (RNUGF), Tetralogic Pharmaceuticals (TLOG), Callitas Health In (MPHMF), Imaging Canada Liquidating (IMRSQ) and Echo Therapeutics (ECTE).
Who are Encision's key executives?
Encision's management team includes the folowing people:
- Patrick W. Pace M.D., Executive Independent Chairman of the Board
- Gregory J. Trudel, President, Chief Executive Officer, Director (Age 54)
- David W. Newton, Co-Founder, Vice President -Technology, Director (Age 68)
- Peter Geary, Vice President - Operations
- Michael Biggs, Vice President- Product Development (Age 45)
- Brad Greathouse, Vice President - Regulatory Affairs & Quality Assurance (Age 55)
- Mala Ray, Controller, Treasurer, corporate Secretary (Age 56)
- Robert H. Fries, Independent Director (Age 66)
- Vern D. Kornelsen CPA, Independent Director (Age 83)
- Ruediger Naumann-Etienne Ph.D., Independent Director (Age 71)
How do I buy Encision stock?
Shares of Encision can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Encision's stock price today?
One share of Encision stock can currently be purchased for approximately $0.40.
How big of a company is Encision?
Encision has a market capitalization of $4.59 million and generates $8.87 million in revenue each year. The medical device company earns $-720,000.00 in net income (profit) each year or $0.03 on an earnings per share basis. Encision employs 35 workers across the globe.
How can I contact Encision?
Encision's mailing address is 6797 WINCHESTER CIRCLE, BOULDER CO, 80301. The medical device company can be reached via phone at 303-444-2600.
MarketBeat Community Rating for Encision (ECIA)MarketBeat's community ratings are surveys of what our community members think about Encision and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Encision (OTCMKTS:ECIA) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Encision (OTCMKTS:ECIA) Earnings History and Estimates Chart
Encision (OTCMKTS ECIA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/9/2018|| || || || || || || || |
|2/5/2018||Q3 2018||$0.01||$2.19 million||View||N/A|
|11/2/2017||Q2 2018||$0.01||$2.16 million||View||N/A|
|7/27/2017||Q1 2018||$0.02||$2.36 million||View||N/A|
|5/10/2017||Q4 2017||($0.01)||$2.21 million||View||N/A|
|2/8/2017||Q3 2017||($0.03)||$2.23 million||View||N/A|
|11/3/2016||Q2 2017||($0.02)||$2.15 million||View||N/A|
|8/2/2016||Q1 2017||($0.01)||$2.28 million||View||N/A|
|5/13/2016||Q4 2016||($0.03)||$2.29 million||View||N/A|
|2/2/2016||Q3 2016||($0.02)||$2.29 million||View||N/A|
|10/28/2015||Q2 2016||($0.02)||$2.30 million||View||N/A|
|8/3/2015||Q1 2016||($0.02)||$2.45 million||View||N/A|
|5/27/2015||Q4 2015||($0.03)||$2.31 million||View||N/A|
|1/30/2015||Q3 2015||($0.04)||$2.61 million||View||N/A|
|10/31/2014||Q2 2015||($0.04)||$2.28 million||View||N/A|
|7/29/2014||Q1 2015||($0.02)||$2.48 million||View||N/A|
|5/21/2014||Q4 2014||($0.03)||$2.50 million||View||N/A|
|11/5/2013||Q2 2014||($0.01)||$2.65 million||View||N/A|
|7/31/2013||Q1 2014||($0.03)||$2.68 million||View||N/A|
|5/14/2013||Q4 2013||($0.03)||$2.74 million||View||N/A|
Encision (OTCMKTS:ECIA) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Encision (OTCMKTS:ECIA)
No dividend announcements for this company have been tracked by MarketBeat.com
Encision (OTCMKTS ECIA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 32.72%
Encision (OTCMKTS ECIA) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/21/2017||Robert H Fries||Director||Buy||20,000||$0.42||$8,400.00||220,000|| |
|8/18/2017||Patrick W Pace||Director||Buy||10,000||$0.41||$4,100.00||98,546|| |
|8/3/2017||Robert H Fries||Director||Buy||20||$0.42||$8.40||200,000|| |
|5/15/2017||Robert H Fries||Director||Buy||10,000||$0.40||$4,000.00||180,000|| |
|2/17/2017||Robert H Fries||Director||Buy||50,000||$0.30||$15,000.00||130,000|| |
|2/16/2017||Gregory J Trudel||CEO||Buy||1,700||$0.30||$510.00||11,625|| |
|5/27/2016||Gregory J Trudel||CEO||Buy||500||$0.35||$175.00||9,925|| |
|3/3/2016||Gregory J Trudel||CEO||Buy||800||$0.35||$280.00||9,425|| |
|2/23/2016||Gregory J Trudel||CEO||Buy||2,000||$0.37||$740.00||7,625|| |
|2/16/2016||Gregory J Trudel||CEO||Buy||1,000||$450.00||$450,000.00||6,625|| |
|3/10/2015||Vern D Kornelsen||Director||Buy||123,908||$0.75||$92,931.00|| |
|2/23/2015||Vern D Kornelsen||Director||Buy||7,574||$0.75||$5,680.50|| |
|2/4/2015||Ruediger Naumann-Etienne||Director||Buy||47,165||$0.82||$38,675.30|| |
|12/16/2014||Michael Biggs||VP||Buy||9,000||$0.80||$7,200.00|| |
|12/16/2014||Vern D Kornelsen||Director||Buy||31,250||$0.80||$25,000.00|| |
|12/15/2014||Ruediger Naumann-Etienne||Director||Buy||12,262||$0.84||$10,300.08|| |
|12/8/2014||Ruediger Naumann-Etienne||Director||Buy||6,500||$0.79||$5,135.00|| |
|12/4/2014||Patrick W Pace||Director||Buy||1,000||$0.09||$90.00|| |
|11/26/2014||Ruediger Naumann-Etienne||Director||Buy||2,000||$0.08||$160.00|| |
|11/24/2014||Ruediger Naumann-Etienne||Director||Buy||2,000||$0.08||$160.00|| |
|11/19/2014||Ruediger Naumann-Etienne||Director||Buy||2,200||$0.75||$1,650.00|| |
|8/8/2014||Patrick W Pace||Director||Buy||10,000||$0.92||$9,200.00|| |
|5/23/2014||Ruediger Naumann-Etienne||Director||Buy||1,500||$0.80||$1,200.00|| |
|12/18/2013||Ruediger Naumann-Etienne||Director||Buy||6,000||$0.80||$4,800.00|| |
|12/4/2013||Ruediger Naumann-Etienne||Director||Buy||5,000||$0.80||$4,000.00|| |
|12/3/2013||Patrick W Pace||Chairman||Buy||2,000||$0.80||$1,600.00|| |
|12/3/2013||Ruediger Naumann-Etienne||Director||Buy||5,000||$0.80||$4,000.00|| |
|12/2/2013||Patrick W Pace||Chairman||Buy||6,347||$0.80||$5,077.60|| |
|12/2/2013||Ruediger Naumann-Etienne||Director||Buy||3,000||$0.80||$2,400.00|| |
|11/27/2013||Ruediger Naumann-Etienne||Director||Buy||8,600||$0.80||$6,880.00|| |
Encision (OTCMKTS ECIA) News Headlines
|Encision (ECIA) Releases Quarterly Earnings Results|
www.americanbankingnews.com - February 6 at 10:21 AM
|Encision Reports Third Quarter Fiscal Year 2018 Results|
www.prnewswire.com - February 5 at 7:10 AM
|Encision Announces Death of VP-Product Development Officer Michael Biggs|
finance.yahoo.com - December 4 at 5:49 PM
|Encision, Inc. :ECIA-US: Earnings Analysis: Q2, 2018 By the Numbers : November 30, 2017|
finance.yahoo.com - November 30 at 5:48 PM
|Encision Inc. (ECIA) Releases Earnings Results|
www.americanbankingnews.com - November 3 at 5:02 PM
|Encision Reports Second Quarter Fiscal Year 2018 Results|
finance.yahoo.com - November 2 at 7:11 PM
|Encision to Present at the 10th Annual LD Micro Main Event Conference|
finance.yahoo.com - November 2 at 7:11 PM
|Encision Inc. (ECIA) Rating Increased to Hold at ValuEngine|
www.americanbankingnews.com - October 14 at 8:52 AM
|Encision Inc. (ECIA) Lowered to Sell at ValuEngine|
www.americanbankingnews.com - October 7 at 11:14 PM
|Encision, Inc. :ECIA-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017|
finance.yahoo.com - September 13 at 7:27 PM
|Encision Inc. (OTCMKTS:ECIA) Announces Earnings Results|
www.americanbankingnews.com - July 28 at 6:19 PM
|Encision Reports First Quarter Fiscal Year 2018 Results|
finance.yahoo.com - July 27 at 6:39 PM
|Encision, Inc. :ECIA-US: Earnings Analysis: Q4, 2017 By the Numbers : June 16, 2017|
finance.yahoo.com - July 14 at 2:27 PM
|ENCISION INC Files SEC form 8-K, Change in Directors or Principal Officers|
biz.yahoo.com - March 22 at 5:01 PM
|ENCISION INC Files SEC form 8-K, Entry into a Material Definitive Agreement|
biz.yahoo.com - November 18 at 4:06 PM
|ENCISION INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligatio|
biz.yahoo.com - March 23 at 2:35 PM
|ENCISION INC Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - February 8 at 9:03 AM
|ENCISION INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders|
biz.yahoo.com - August 12 at 6:03 AM
|ENCISION INC Files SEC form 10-K, Annual Report|
biz.yahoo.com - June 19 at 9:05 AM
|ENCISION INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
biz.yahoo.com - June 3 at 12:55 PM
Encision (OTCMKTS:ECIA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Encision (OTCMKTS:ECIA) Income Statement, Balance Sheet and Cash Flow Statement
Encision (OTCMKTS ECIA) Stock Chart for Saturday, February, 24, 2018